IRIS
FRATI, Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.613
EU - Europa 3.131
AS - Asia 1.647
AF - Africa 16
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 8.424
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.557
CN - Cina 988
IT - Italia 613
IE - Irlanda 600
SE - Svezia 536
FI - Finlandia 524
SG - Singapore 484
DE - Germania 306
UA - Ucraina 187
TR - Turchia 113
FR - Francia 112
AT - Austria 73
GB - Regno Unito 55
BE - Belgio 52
CA - Canada 51
IN - India 32
CZ - Repubblica Ceca 26
CI - Costa d'Avorio 14
NL - Olanda 14
VN - Vietnam 11
LT - Lituania 10
BR - Brasile 7
EU - Europa 6
JP - Giappone 6
HK - Hong Kong 4
CH - Svizzera 3
ES - Italia 3
IR - Iran 3
RS - Serbia 3
RU - Federazione Russa 3
SK - Slovacchia (Repubblica Slovacca) 3
AU - Australia 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
RO - Romania 2
BS - Bahamas 1
BT - Bhutan 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 8.424
Salva come PNG Salva come JPEG
Città #
Chandler 623
Dublin 600
Singapore 353
Parma 316
Santa Clara 297
Jacksonville 247
Ann Arbor 246
Dearborn 242
Ashburn 224
Boardman 196
Nanjing 162
Beijing 154
Shanghai 130
Princeton 101
Wilmington 101
Izmir 95
New York 91
Bremen 74
Vienna 69
Helsinki 66
Jinan 57
Padova 56
Nanchang 53
Brussels 52
San Mateo 51
Seattle 50
Shenyang 42
Des Moines 37
Kunming 36
Toronto 35
Hebei 33
Changsha 32
Hefei 31
Munich 31
Tulsa 26
Guangzhou 22
Jiaxing 20
Woodbridge 20
Fremont 16
Houston 16
Norwalk 16
Zhengzhou 16
Frankfurt am Main 15
London 15
Abidjan 14
Kocaeli 14
Los Angeles 14
Ningbo 14
Pune 14
Tianjin 14
Haikou 13
Marseille 13
Dallas 12
Hangzhou 12
Rio Saliceto 12
Chicago 11
Lanzhou 11
Milan 11
Dong Ket 10
Modena 10
Monmouth Junction 10
Olomouc 10
Taizhou 10
Brno 9
Falkenstein 9
Amsterdam 8
Taiyuan 8
Falls Church 7
Fuzhou 7
Ottawa 7
Redwood City 7
Düsseldorf 6
Grafing 6
Rome 6
Bologna 5
Chengdu 5
Redmond 5
Rockville 5
Washington 5
Ardea 4
Busseto 4
Genova 4
Leawood 4
Mirandola 4
Borgonovo Val Tidone 3
Boston 3
Bratislava 3
Edinburgh 3
Istanbul 3
Mumbai 3
Napoli 3
Pavia 3
Piacenza 3
Strasbourg 3
Tappahannock 3
Torre Annunziata 3
Ardabil 2
Assago 2
Augusta 2
Bangalore 2
Totale 5.563
Salva come PNG Salva come JPEG
Nome #
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 182
Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart 168
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 168
Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. 164
Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue 158
Cobalt oxide nanoparticles induce oxidative stress and alter electromechanical function in rat ventricular myocytes 152
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats 147
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 134
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 132
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 125
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 120
Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats 115
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 113
Imatinib Mesylate Induced Cardiotoxicity: a Cardiac Progenitor Cell Disease? 108
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 108
Mobilization of cardiac progenitor cells by Hepatocyte Growth Factor (HGF) and Insulin-like Growth Factor-1 (IGF-1) for repairing chronic myocardial infarction (MI) is not proarrhytmic. 107
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 106
Microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in vitro e in vivo. 105
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 104
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 103
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 103
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 99
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 98
Isolation and characterization of human lung lymphatic endothelial cells 97
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 95
Repair of chronic myocardial infarction (MI) induced by mobilization of cardiac progenitor cells (CPCs) via local delivery of hapatocyte growth factor (HGF) and insulin-like growth factor-1 (IGF-1) is not proarrhythmic. 93
Resident cardiac stem cells. 92
Tyrosine kinase cardiotoxicity: ultrastructural analysis of imatinib mesylate induced cardiomyopathy 92
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 91
Amelioration of cardiac electrical performance following stem cell based regenerative therapies, in infarcted rat heart 90
Studio in vitro ed in vivo della biocompatibilità di PAM (pharmacologically active microcarriers) come substrato per la rigenerazione miocardica 89
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 89
Electromechanical competence of the myocardium regenerated by growth factors and cell therapy in ischemic cardiomyopathy. 89
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 89
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 88
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 86
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico. 85
High-resolution X-ray microtomography for three-dimensional imaging of cardiac progenitor cell homing in infarcted rat hearts 85
Imatinib mesylate induced cardiotoxicity: a cardiac progenitor cell disease? 85
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 85
High-Resolution X-Ray Microtomography for Three-Dimensional Visualization of Cardiac Progenitor Cells Homing in Infarcted Rat Hearts 85
Stem cells and myocardial regeneration 84
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 82
Functional recovery of the infarcted heart mediated by pharmacologically active microcarriers conveying human adipose-derived stem cells and/or releasing growth factors 81
Cardiac electromechanical performance following stem cell based regenerative therapies in infarcted rat heart. 80
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients 80
Assessment of Cardiac Patches Suitability for Tissue Engineering 80
Characterization of ABC transporters in epiairway™, a cellular model of normal human bronchial epithelium 80
Effetti del Growth Hormone sulla riparazione dell’infarto miocardico acuto. 79
Phase-contrast microtomography: are the tracers necessary for stem cell tracking in infarcted hearts? 79
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 77
Comet assay and prediction of clinical outcome after DNA-damaging drugs treatment 77
Diabetes Impairs Bone Marrow Microenvironment Affecting Progenitor Cell Number, Mobilization and Engraftment in Humans. 75
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 75
Electrical stability of infarcted rat hearts following treatment with stem cells 74
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 74
Caratterizzazione strutturale ed identificazione dei fenotipi staminali della placenta umana 74
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico 74
Role of cardiac lymphatic vessels in ischemic and drug induced cardiomyopathy 74
Caratterizzazione strutturale ed identificazione dei fenotipi staminali della placenta umana 73
Bioactive Electrospun Fibers of Poly(glycerol sebacate) and Poly(ε-caprolactone) for Cardiac Patch Application 72
Cellule mesenchimali placentari: una risorsa per la vasculogenesi 72
Mobilization of cardiac progenitor cells by hepatocyte growth factor and insulin-like growth factor-1 for repairing chronic myocardial infarction is not proarrhythmic. 71
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 70
SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells 69
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 68
Studio del potenziale cardiogenico in vitro di monocolture e cocolture di cellule miocardiche e midollari 67
Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application 67
Enhanced engraftment and repairing ability of human adipose-derived stem cells, conveyed by pharmacologically active microcarriers continuously releasing HGF and IGF-1, in healing myocardial infarction in rats 67
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 64
Rigenerazione miocardica mediata da cellule staminali: potenziale endogeno e fonti extracardiache 64
High-resolution X-ray microtomography for three-dimensional visualization of Cardiac Progenitor Cells Homing in infarcted rat hearts. 64
LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS 64
Early antioxidant treatment with resveratrol: a new therapeutic approach for preventing diabetic cardiomyopathy 63
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 63
Doxorubicin induces senescence and impairs function of human cardiac progenitor cells 62
Il potenziale rigenerativo miocardico di cellule umane di diversa origine 61
Rigenerazione mediata da cellule staminali: potenziale endogeno e fonti extracardiache 61
GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy 60
Uso di microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in modelli di ratto di infarto miocardico 60
QUALI CELLULE UTILIZZARE PER LA RIGNERAZIONE DEL MIOCARDIO? 59
Il Cuore, il Midollo Osseo e la Placenta come fonti di terapia cellulare per la rigenerazione cardiaca 58
IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium 56
Syngeneic cardiac and bone marrow stromal cells display tissue-specific microRNA signatures and microRNA subsets restricted to diverse differentiation processes 56
Pharmacologically active microcarriers conveying human adipose-derived stem cells and/or releasing growth factors in myocardial regeneration 55
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 55
Correction: A versatile bioreactor for dynamic suspension cell culture. Application to the culture of cancer cell spheroids 55
Influence of injectable microparticle size on cardiac progenitor cell response 55
Development of biomimetic alginate/gelatin/elastin sponges with recognition properties toward bioactive peptides for cardiac tissue engineering 52
Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin. 52
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 51
Reinforced alginate/gelatin sponges functionalized by avidin/biotin-binding strategy: a novel cardiac patch 51
IDENTIFICATION OF HUMAN UNSELECTED MESENCHYMAL-LIKE MYOCARDIAL CELLS: Stem Cells for Myocardial Regeneration 50
Isolation and Characterization of Cardiogenic Cells from the Adult Hypertrophic Human Heart 50
Detection of DNA strand breaks and cell death as individual predictive response to Gemtuzumab Ozogamicin in Acute Myeloid Leucemia 48
Is there a way to predict the clinical outcome of DNA strand breaks generating drugs? The case of calicheamicin 47
In vitro cardiogenic potential of human myocardial and marrow stromal cells. 46
In vitro suspension bioreactor-based platform for culturing tumor cell clusters 45
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 44
DETECTION OF DNA STRAND BREAK AS INDIVIDUAL PREDICTIVE RESPONSE TO GEMTUZUMAB OZOGAMICIN IN ACUTE MYELOID LEUKEMIA 42
Totale 8.332
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.389
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020794 0 0 0 0 0 214 164 29 139 140 37 71
2020/2021729 11 65 32 20 92 32 73 40 173 46 116 29
2021/2022510 26 16 15 25 14 12 71 57 22 36 28 188
2022/20232.447 250 268 180 179 248 269 38 140 717 9 110 39
2023/2024943 47 79 24 16 77 235 87 76 28 62 101 111
2024/20251.105 43 128 162 199 314 259 0 0 0 0 0 0
Totale 8.560